-
Je něco špatně v tomto záznamu ?
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
D. Stastna, I. Menkyova, J. Drahota, T. Hrnciarova, E. Kubala Havrdova, M. Vachova, M. Andelova, P. Kleinova, I. Kovarova, E. Krasulova, JL. Preiningerova, I. Novakova, K. Novotna, M. Novotna, P. Nytrova, J. Pavlickova, B. Srpova, K. Storey, V....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, pozorovací studie
- MeSH
- COVID-19 * prevence a kontrola MeSH
- lidé MeSH
- neuromyelitis optica * komplikace MeSH
- recidiva MeSH
- retrospektivní studie MeSH
- roztroušená skleróza * komplikace MeSH
- vakcína BNT162 MeSH
- vakcinace škodlivé účinky MeSH
- vakcíny proti COVID-19 * škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: COVID-19 vaccination and infection are speculated to increase the activity of immune-mediated diseases, including multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). The aim of this study was to evaluate a short-term risk of relapse after COVID-19 vaccination and COVID-19 infection in patients with these demyelinating disorders of the central nervous system and to determine disease exacerbation risk factors. METHODS: Data in this retrospective, observational cohort study was collected via the Czech nationwide registry ReMuS from March 1, 2020, to October 30, 2021. We compared the proportion of patients with at least one clinical relapse in the 90 days following vaccination or infection to the 90-day intervals during the year before. For the evaluation of the risk factors of relapse, a comparison between groups with and without relapses after COVID-19 vaccination or infection was made. RESULTS: We identified 1661 vaccinated (90.11% BNT162b2) patients with MS without a history of COVID-19 and 495 unvaccinated patients with MS who experienced COVID-19. A mild increase in the proportion of patients with at least one clinical relapse (-360 to -270 days: 4.46%; -270 to -180: 4.27%; -180 to -90: 3.85%; -90 to 0: 3.79% vs. 0 to +90 days: 5.30%) after vaccination in patients with MS was observed, as well as a rise in the proportion of patients with at least one clinical relapse after COVID-19. Lower age was associated with MS relapse after vaccination or infection. Although there were only 17 vaccinated and eight post-COVID-19 patients with NMOSD, the results were broadly consistent with those of patients with MS. CONCLUSION: There is a mild increase in the relapse incidence after the COVID-19 vaccination. The risks, however, need to be balanced against the risks of COVID-19 itself, also leading to the rise in relapse rate and particularly to morbidity and mortality.
2nd Department of Neurology Faculty of Medicine Comenius University Bratislava Slovakia
Department of Neurology KZ a s Hospital Teplice Teplice Czechia
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024643
- 003
- CZ-PrNML
- 005
- 20240903112843.0
- 007
- ta
- 008
- 221017e20220702ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.msard.2022.104014 $2 doi
- 035 __
- $a (PubMed)35803085
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Stastna, Dominika $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 245 10
- $a To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection / $c D. Stastna, I. Menkyova, J. Drahota, T. Hrnciarova, E. Kubala Havrdova, M. Vachova, M. Andelova, P. Kleinova, I. Kovarova, E. Krasulova, JL. Preiningerova, I. Novakova, K. Novotna, M. Novotna, P. Nytrova, J. Pavlickova, B. Srpova, K. Storey, V. Ticha, M. Tyblova, T. Uher, K. Vodehnalova, D. Horakova
- 520 9_
- $a BACKGROUND: COVID-19 vaccination and infection are speculated to increase the activity of immune-mediated diseases, including multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). The aim of this study was to evaluate a short-term risk of relapse after COVID-19 vaccination and COVID-19 infection in patients with these demyelinating disorders of the central nervous system and to determine disease exacerbation risk factors. METHODS: Data in this retrospective, observational cohort study was collected via the Czech nationwide registry ReMuS from March 1, 2020, to October 30, 2021. We compared the proportion of patients with at least one clinical relapse in the 90 days following vaccination or infection to the 90-day intervals during the year before. For the evaluation of the risk factors of relapse, a comparison between groups with and without relapses after COVID-19 vaccination or infection was made. RESULTS: We identified 1661 vaccinated (90.11% BNT162b2) patients with MS without a history of COVID-19 and 495 unvaccinated patients with MS who experienced COVID-19. A mild increase in the proportion of patients with at least one clinical relapse (-360 to -270 days: 4.46%; -270 to -180: 4.27%; -180 to -90: 3.85%; -90 to 0: 3.79% vs. 0 to +90 days: 5.30%) after vaccination in patients with MS was observed, as well as a rise in the proportion of patients with at least one clinical relapse after COVID-19. Lower age was associated with MS relapse after vaccination or infection. Although there were only 17 vaccinated and eight post-COVID-19 patients with NMOSD, the results were broadly consistent with those of patients with MS. CONCLUSION: There is a mild increase in the relapse incidence after the COVID-19 vaccination. The risks, however, need to be balanced against the risks of COVID-19 itself, also leading to the rise in relapse rate and particularly to morbidity and mortality.
- 650 _2
- $a vakcína BNT162 $7 D000090982
- 650 12
- $a COVID-19 $x prevence a kontrola $7 D000086382
- 650 12
- $a vakcíny proti COVID-19 $x škodlivé účinky $7 D000086663
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a roztroušená skleróza $x komplikace $7 D009103
- 650 12
- $a neuromyelitis optica $x komplikace $7 D009471
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a vakcinace $x škodlivé účinky $7 D014611
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Menkyova, Ingrid $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia; 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
- 700 1_
- $a Drahota, Jiri $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia; Endowment Fund IMPULS, Prague, Czechia
- 700 1_
- $a Hrnciarova, Tereza $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Kubala Havrdova, Eva $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Vachova, Marta $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia; Department of Neurology, KZ a.s., Hospital Teplice, Teplice, Czechia
- 700 1_
- $a Andelova, Michaela $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Kleinova, Pavlina $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Kovarova, Ivana $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Krasulova, Eva $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Preiningerova, Jana Lizrova $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Novakova, Iveta $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Novotna, Klara $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Novotna, Martina $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Nytrova, Petra $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Pavlickova, Jana $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Srpová, Barbora $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia $7 xx0321726
- 700 1_
- $a Storey, Katerina $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Ticha, Veronika $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Tyblova, Michaela $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Uher, Tomas $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Vodehnalova, Karolina $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia
- 700 1_
- $a Horakova, Dana $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia. Electronic address: dana.horakova@vfn.cz
- 773 0_
- $w MED00188780 $t Multiple sclerosis and related disorders $x 2211-0356 $g Roč. 65 (20220702), s. 104014
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35803085 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20240903112840 $b ABA008
- 999 __
- $a ok $b bmc $g 1854401 $s 1175933
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 65 $c - $d 104014 $e 20220702 $i 2211-0356 $m Multiple sclerosis and related disorders $n Mult Scler Relat Disord $x MED00188780
- LZP __
- $a Pubmed-20221017